Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:HTWR

(HTWR) (HTWR) Stock Price, News & Analysis

(HTWR) logo

About (HTWR) Stock (NASDAQ:HTWR)

Advanced Chart

Key Stats

Today's Range
$57.98
$57.98
50-Day Range
N/A
52-Week Range
$25.01
$87.38
Volume
N/A
Average Volume
528,597 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Heartware International, Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The Company operates in the segment of design and manufacture of medical devices. The HeartWare Ventricular Assist System (HVAD System), which includes a ventricular assist device (VAD) or blood pump, patient accessories and surgical tools, provides circulatory support for patients in the advanced stage of heart failure. The HVAD System is designed to be implanted adjacent to the heart, avoiding abdominal surgery. The HVAD System features the centrifugal pump designed to be implanted in the chest, directly adjacent to the heart. It develops MVAD System, a miniaturized device. The CircuLite Surgical System is designed to be implanted through a right, mini-thoracotomy procedure and does not require a sternotomy or cardiopulmonary bypass.

Receive HTWR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (HTWR) and its competitors with MarketBeat's FREE daily newsletter.

HTWR Stock News Headlines

Waga Energy SA WAGA
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

HTWR Stock Analysis - Frequently Asked Questions

(HTWR) (NASDAQ:HTWR) released its earnings results on Thursday, July, 28th. The medical instruments supplier reported ($0.43) earnings per share for the quarter, beating analysts' consensus estimates of ($0.82) by $0.39. The firm's revenue for the quarter was down 6.6% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that (HTWR) investors own include Nuwellis (CHFS), Netflix (NFLX), Bristol-Myers Squibb (BMY), (MDVN) (MDVN), AllianceBernstein (AB), Align Technology (ALGN) and Arctos NorthStar Acquisition (ANAC).

Company Calendar

Last Earnings
7/28/2016
Today
5/29/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:HTWR
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:HTWR) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners